Old Web
English
Sign In
Acemap
>
authorDetail
>
Anne-Marie Young
Anne-Marie Young
Hoffmann-La Roche
Medicine
Pharmacology
Pharmacokinetics
Internal medicine
Drug interaction
5
Papers
28
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase 1 study of the MDM2 antagonist RO6839921 in patients with acute myeloid leukemia
2020
Investigational New Drugs
Geoffrey L. Uy
Sarit Assouline
Anne-Marie Young
Steven Blotner
Brian Higgins
Lin-Chi Chen
Karen W.L. Yee
Show All
Source
Cite
Save
Citations (2)
A phase 1 study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, in patients with advanced solid tumors
2019
Investigational New Drugs
Albiruni R. Razak
Wilson H. Miller
Geoffrey L. Uy
Steven Blotner
Anne-Marie Young
Brian Higgins
Lin-Chi Chen
Lia Gore
Show All
Source
Cite
Save
Citations (4)
Aleglitazar, a balanced PPARα/γ agonist, has no clinically relevant pharmacokinetic interaction with high-dose atorvastatin or rosuvastatin
2011
Expert Opinion on Investigational Drugs
Adam J Foley-Comer
Anne-Marie Young
Fiona Russell-Yarde
Paul Jordan
Show All
Source
Cite
Save
Citations (5)
No clinically relevant drug–drug interactions when dalcetrapib is co-administered with atorvastatin
2010
Expert Opinion on Investigational Drugs
Michael Derks
Markus Abt
Graeme Parr
Georgina Meneses-Lorente
Anne-Marie Young
Mary Phelan
Show All
Source
Cite
Save
Citations (17)
No Clinically Relevant Drug-Drug Interactions Between Dalcetrapib and a Monophasic Oral Contraceptive (Microgynon-30®)
2010
Journal of Clinical Lipidology
Anne-Marie Young
Adam Foley-Comer
Judith Anzures-Cabrera
Michael Derks
Show All
Source
Cite
Save
Citations (0)
1